Entera Bio Balance Sheet Health
Financial Health criteria checks 6/6
Entera Bio has a total shareholder equity of $10.4M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $11.8M and $1.4M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$11.02m |
| Equity | US$10.39m |
| Total liabilities | US$1.38m |
| Total assets | US$11.77m |
Recent financial health updates
Here's Why We're Not Too Worried About Entera Bio's (NASDAQ:ENTX) Cash Burn Situation
Mar 23
We're Keeping An Eye On Entera Bio's (NASDAQ:ENTX) Cash Burn Rate
May 31Will Entera Bio (NASDAQ:ENTX) Spend Its Cash Wisely?
Feb 15Is Entera Bio (NASDAQ:ENTX) In A Good Position To Deliver On Growth Plans?
Oct 13Recent updates
Here's Why We're Not Too Worried About Entera Bio's (NASDAQ:ENTX) Cash Burn Situation
Mar 23We're Keeping An Eye On Entera Bio's (NASDAQ:ENTX) Cash Burn Rate
May 31Will Entera Bio (NASDAQ:ENTX) Spend Its Cash Wisely?
Feb 15Is Entera Bio (NASDAQ:ENTX) In A Good Position To Deliver On Growth Plans?
Oct 13Entera Bio GAAP EPS of -$0.24 , revenue of $0.11M
Aug 11We Think Entera Bio (NASDAQ:ENTX) Needs To Drive Business Growth Carefully
Jun 10Companies Like Entera Bio (NASDAQ:ENTX) Are In A Position To Invest In Growth
Jan 21We're Interested To See How Entera Bio (NASDAQ:ENTX) Uses Its Cash Hoard To Grow
Oct 06Here's Why We're Not Too Worried About Entera Bio's (NASDAQ:ENTX) Cash Burn Situation
Jun 19Entera Bio secures European patent for oral PTH formulations
Jun 17We're Keeping An Eye On Entera Bio's (NASDAQ:ENTX) Cash Burn Rate
Mar 20Here's Why Entera Bio (NASDAQ:ENTX) Must Use Its Cash Wisely
Dec 05
Entera Bio EPS misses by $0.22
Nov 19Entera Bio completes enrollment in Phase 2 trial of EB613 in Osteoporosis
Nov 09Financial Position Analysis
Short Term Liabilities: ENTX's short term assets ($11.3M) exceed its short term liabilities ($1.1M).
Long Term Liabilities: ENTX's short term assets ($11.3M) exceed its long term liabilities ($288.0K).
Debt to Equity History and Analysis
Debt Level: ENTX is debt free.
Reducing Debt: ENTX had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: ENTX has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: ENTX has sufficient cash runway for 1.4 years if free cash flow continues to reduce at historical rates of 3.9% each year.